Chemotherapy in advanced non-small-cell lung cancer may be a controversy because it is only palliative and costly. Benefit of chemotherapy is nevertheless clear in survival and particularly life quality. Beside this technical criteria, two other factors have an impact on the therapeutic decision: symptom control and patient's personal expectations. The aim of the strategy is to determine an acceptable compromise in each situation.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
lung cancer
8
[advanced nonsmall
4
nonsmall cell
4
cell lung
4
cancer chemotherapy
4
chemotherapy control
4
control symptoms]
4
symptoms] chemotherapy
4
chemotherapy advanced
4
advanced non-small-cell
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!